TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis
TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis
复制标题
DOI:
10.1038/sj.onc.1209568
复制
发表时间:
2006-09-14
期刊:
影响因子:
8
通讯作者:
Gulbins, E.
中科院分区:
文献类型:
--
作者:
Dumitru, C. A.;Gulbins, E.
We have previously shown that activation of the acid sphingomyelinase (ASM), the release of ceramide and the formation of ceramide-enriched membrane domains are central for the induction of apoptosis by CD95. Here, we demonstrate that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and CD95 activate the ASM via a redox mechanism resulting in release of ceramide and formation of ceramide-enriched membrane platforms. Ceramide-enriched membrane platforms serve to cluster DR5 upon stimulation. Antioxidants prevent TRAIL-mediated stimulation of ASM, the release of ceramide, the formation of ceramide-enriched membrane platforms and the induction of apoptosis by TRAIL. Further, ASM-deficient splenocytes fail to cluster DR5 in ceramide-enriched membrane domains upon TRAIL stimulation and resist TRAIL-induced apoptosis, events that were restored by addition of natural C-16-ceramide. A dose-response analysis indicates that ceramide-enriched membrane platforms greatly sensitized tumor cells to TRAIL-induced apoptosis. Our data indicate that ceramide-enriched membrane platforms are required for the signaling of TRAIL-DR5 complexes under physiological conditions.